|
|
Latest Story |
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules |
GlobeNewswire |
Full Story → |
Headline News |
Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients |
7:00a ET April 18 '24 GlobeNewswire |
Bio-Path Holdings Expands Global Patent Portfolio |
7:00a ET April 15 '24 GlobeNewswire |
Bio-Path Holdings Provides 2024 Clinical and Operational Update |
7:00a ET April 2 '24 GlobeNewswire |
More News → |
|
Today, 10:16a ET Friday April 19 '24. Markets Open. | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Previous data from yesterday, April 18 '24. |